Is US Stem Cell, Inc. (OTCPK:USRM) Fairly Valued? – Wall Street Herald
|
Is US Stem Cell, Inc. (OTCPK:USRM) Fairly Valued?
Wall Street Herald In trying to determine the current valuation of U.S. Stem Cell, Inc. (OTCPK:USRM) shares, we note that the Book to Market ratio of the shares stands at -0.312724. It's commonly accepted that a Book to Market ratio greater than one indicates that the … |
